TriMas (TRS) 10-Q 29 Oct 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	9 Months Ended
	Sep. 30, 2020	Oct. 21, 2020
Entity Information [Line Items]
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common stock, $0.01 par value
Document Transition Report	false
Document Quarterly Report	true
Local Phone Number	631-5450
City Area Code	248
Entity Address, Postal Zip Code	48304
Entity Address, State or Province	MI
Entity Address, City or Town	Bloomfield Hills
Entity Address, Address Line Two	Suite 200
Entity Address, Address Line One	38505 Woodward Avenue
Entity File Number	001-10716
Entity Shell Company	false
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Registrant Name	TRIMAS CORPORATION
Entity Central Index Key	0000842633
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		43,225,130
Entity Small Business	false
Entity Emerging Growth Company	false
Trading Symbol	TRS
Security Exchange Name	NASDAQ
Entity Tax Identification Number	38-2687639

Consolidated Balance Sheet Stat

Consolidated Balance Sheet Statement - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 99,740	$ 172,470
Receivables, net of reserves of approximately $3.3 million and $2.1 million as of September 30, 2020 and December 31, 2019, respectively	118,750	108,860
Inventories	142,600	132,660
Prepaid expenses and other current assets	13,640	20,050
Total current assets	374,730	434,040
Property and equipment, net	215,630	214,330
Operating lease right-of-use assets	36,050	27,850
Goodwill	251,870	334,640
Other intangibles, net	175,590	161,390
Deferred income taxes	5,720	500
Other assets	15,930	19,950
Total assets	1,075,520	1,192,700
Current liabilities:
Accounts payable	59,530	72,670
Accrued liabilities	56,410	42,020
Operating lease liabilities, current portion	6,940	5,100
Total current liabilities	122,880	119,790
Long-term debt, net	295,550	294,690
Operating lease liabilities	29,650	23,100
Deferred income taxes	12,220	16,830
Other long-term liabilities	57,250	40,810
Total liabilities	517,550	495,220
Preferred stock $0.01 par: Authorized 100,000,000 shares; Issued and outstanding: None	0	0
Common stock, $0.01 par: Authorized 400,000,000 shares; Issued and outstanding: 43,318,056 shares at September 30, 2020 and 44,562,679 shares at December 31, 2019	430	450
Paid-in capital	749,860	782,880
Accumulated deficit	(183,300)	(79,850)
Accumulated other comprehensive loss	(9,020)	(6,000)
Total shareholders' equity	557,970	697,480
Total liabilities and shareholders' equity	$ 1,075,520	$ 1,192,700

Consolidated Balance Sheet Pare

Consolidated Balance Sheet Parentheticals - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Receivables, reserves (in dollars)	$ 3.7	$ 2.1
Stockholders' Equity:
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, Authorized shares	100,000,000	100,000,000
Preferred stock, Issued Shares	0	0
Preferred stock, outstanding Shares	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, Authorized shares	400,000,000	400,000,000
Common Stock, Issued Shares	43,318,056	44,562,679
Common Stock, outstanding Shares	43,318,056	44,562,679

Consolidated Statement of Opera

Consolidated Statement of Operations Statement - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net sales	$ 199,460	$ 188,410	$ 581,800	$ 552,610
Cost of sales	(147,530)	(139,420)	(446,270)	(403,040)
Gross profit	51,930	48,990	135,530	149,570
Selling, general and administrative expenses	(25,650)	(25,420)	(107,570)	(79,140)
Impairment of goodwill and indefinite-lived intangible assets	(134,600)	0	(134,600)	0
Operating profit (loss)	(108,320)	23,570	(106,640)	70,430
Other expense, net:
Interest expense	(3,450)	(3,520)	(11,260)	(10,450)
Other income (expense), net	(1,200)	600	(150)	1,250
Other expense, net	(4,650)	(2,920)	(11,410)	(9,200)
Income (loss) before income tax expense	(112,970)	20,650	(118,050)	61,230
Income tax benefit (expense)	12,100	(5,410)	14,600	(12,720)
Income (loss) from continuing operations	(100,870)	15,240	(103,450)	48,510
Income from discontinued operations, net of tax	0	3,870	0	11,710
Net income (loss)	$ (100,870)	$ 19,110	$ (103,450)	$ 60,220
Basic earnings (loss) per share
Continuing operations	$ (2.32)	$ 0.34	$ (2.37)	$ 1.07
Discontinued operations	0	0.08	0	0.26
Net income (loss) per share	$ (2.32)	$ 0.42	$ (2.37)	$ 1.33
Weighted average common shares—basic	43,457,704	45,175,244	43,707,331	45,448,711
Diluted earnings (loss) per share
Continuing operations	$ (2.32)	$ 0.34	$ (2.37)	$ 1.06
Discontinued operations	0	0.08	0	0.26
Net income (loss) per share	$ (2.32)	$ 0.42	$ (2.37)	$ 1.32
Weighted average common shares—diluted	43,457,704	45,415,767	43,707,331	45,745,421

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net Income (loss)	$ (100,870)	$ 19,110	$ (103,450)	$ 60,220
Other comprehensive income (loss)
Defined benefit plans	160	100	470	300
Foreign currency translation	5,740	(4,180)	(1,210)	(4,380)
Derivative instruments	(4,580)	4,260	(2,280)	5,750
Total other comprehensive income (loss)	1,320	180	(3,020)	1,670
Total comprehensive income (loss)	$ (99,550)	$ 19,290	$ (106,470)	$ 61,890

Consolidated Statement of Cash

Consolidated Statement of Cash Flows Statement - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net Income (loss)	$ (103,450)	$ 60,220
Income from discontinued operations, net of tax	0	11,710
Income (loss) from continuing operations	(103,450)	48,510
Adjustments to reconcile income (loss) to net cash provided by operating activities, net of acquisition impact:
Impairment of goodwill and indefinite-lived intangible assets	134,600	0
Loss on dispositions of assets	1,080	60
Depreciation	21,700	18,330
Amortization of intangible assets	15,460	14,030
Amortization of debt issue costs	860	850
Deferred income taxes	(17,790)	5,530
Non-cash compensation expense	5,610	4,130
Non-cash asbestos-related expense for change in liability estimate	23,400	0
Increase in receivables	(6,210)	(8,380)
Decrease in inventories	4,510	(560)
Decrease in prepaid expenses and other assets	5,500	4,780
Increase (decrease) in accounts payable and accrued liabilities	(7,410)	(26,760)
Other operating activities	1,250	90
Net cash provided by operating activities of continuing operations	79,110	60,610
Net cash used for operating activities of discontinued operations	0	3,490
Net cash provided by operating activities, net of acquisition impact	79,110	64,100
Cash Flows from Investing Activities:
Capital expenditures	(17,670)	(22,000)
Acquisition of businesses, net of cash acquired	(95,160)	(67,090)
Net proceeds from disposition of business, property and equipment	1,930	10
Net cash used for investing activities of continuing operations	(110,900)	(89,080)
Net cash used for investing activities of discontinued operations	0	(1,350)
Net cash used for investing activities	(110,900)	(90,430)
Cash Flows from Financing Activities:
Proceeds from borrowings on revolving credit facilities	300,950	145,540
Repayments of borrowings on revolving credit facilities	(303,240)	(145,090)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(2,600)	(3,240)
Payments to purchase common stock	(36,050)	(21,090)
Net cash used for financing activities of continuing operations	(40,940)	(23,880)
Net cash provided by financing activities of discontinued operations	0	0
Net cash used for financing activities	(40,940)	(23,880)
Decrease for the period	(72,730)	(50,210)
At beginning of period	172,470	108,150
At end of period	99,740
Supplemental disclosure of cash flow information:
Cash paid for interest	7,490	6,570
Cash paid for taxes	$ 6,660	$ 15,690

Consolidated Statement of Share

Consolidated Statement of Shareholders' Equity Statement - USD ($) $ in Thousands	Total	Common Stock [Member]	Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income [Member]
Balances at Dec. 31, 2018	$ 620,450	$ 460	$ 816,500	$ (179,660)	$ (16,850)
Net income (loss)	19,090			19,090
Other comprehensive income (loss)	3,020				3,020
Purchase of common stock	(670)		(670)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(2,620)		(2,620)
Non-cash compensation expense	1,320		1,320
Impact of adoption of new accounting pronouncement	(80)			1,190	(1,270)
Balances at Mar. 31, 2019	640,510	460	814,530	(159,380)	(15,100)
Balances at Dec. 31, 2018	620,450	460	816,500	(179,660)	(16,850)
Net income (loss)	60,220
Other comprehensive income (loss)	1,670				1,670
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(3,240)
Balances at Sep. 30, 2019	662,060	450	796,310	(118,250)	(16,450)
Balances at Mar. 31, 2019	640,510	460	814,530	(159,380)	(15,100)
Net income (loss)	22,020			22,020
Other comprehensive income (loss)	(1,530)				(1,530)
Purchase of common stock	(14,750)	(10)	(14,740)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(610)		(610)
Non-cash compensation expense	1,720		1,720
Balances at Jun. 30, 2019	647,360	450	800,900	(137,360)	(16,630)
Net income (loss)	19,110			19,110
Other comprehensive income (loss)	180				180
Purchase of common stock	(5,670)		(5,670)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(10)		(10)
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition	1,090		1,090
Balances at Sep. 30, 2019	662,060	450	796,310	(118,250)	(16,450)
Balances at Dec. 31, 2019	697,480	450	782,880	(79,850)	(6,000)
Net income (loss)	13,120			13,120
Other comprehensive income (loss)	(3,680)				(3,680)
Purchase of common stock	(31,570)	(20)	(31,550)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(1,830)		(1,830)
Non-cash compensation expense	1,940		1,940
Balances at Mar. 31, 2020	675,460	430	751,440	(66,730)	(9,680)
Balances at Dec. 31, 2019	697,480	450	782,880	(79,850)	(6,000)
Net income (loss)	(103,450)
Other comprehensive income (loss)	(3,020)				(3,020)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(2,600)
Balances at Sep. 30, 2020	557,970	430	749,860	(183,300)	(9,020)
Balances at Mar. 31, 2020	675,460	430	751,440	(66,730)	(9,680)
Net income (loss)	(15,700)			(15,700)
Other comprehensive income (loss)	(660)				(660)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(740)		(740)
Non-cash compensation expense	2,740	10	2,730
Balances at Jun. 30, 2020	661,100	440	753,430	(82,430)	(10,340)
Net income (loss)	(100,870)			(100,870)
Other comprehensive income (loss)	1,320				1,320
Purchase of common stock	(4,480)		(4,470)
Shares surrendered upon exercise and vesting of equity awards to cover taxes	(30)		(30)
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition	930		930
Balances at Sep. 30, 2020	$ 557,970	$ 430	$ 749,860	$ (183,300)	$ (9,020)

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation TriMas Corporation ("TriMas" or the "Company"), and its consolidated subsidiaries, designs, engineers and manufactures innovative products under leading brand names for customers primarily in the consumer products, aerospace & defense, and industrial markets. In the second quarter of 2020, the Company elected to change its method of accounting for asbestos-related defense costs from accruing for probable and reasonably estimable defense costs associated with known claims expected to settle to accrue for all future defense costs for both known and unknown claims, which the Company now believes are reasonably estimable. The Company believes this change is preferable, as asbestos-related defense costs represent expenditures related to legacy activities that do not contribute to current or future revenue generating activities, and recording an estimate of the full liability for asbestos-related costs, where estimable with reasonable precision, provides a more complete assessment of the liability associated with resolving asbestos-related claims. This accounting change has been reflected as a change in accounting estimate effected by a change in accounting principle. See Note 15, "Commitments and Contingencies," for further information on this change. In the first quarter of 2020, TriMas began reporting its machined components operations, located in Stanton, California and Tolleson, Arizona, as part of its Aerospace segment. The operations were previously reported in the Specialty Products segment. The move of these operations into TriMas Aerospace facilitates a more rapid approach to achieving anticipated synergies from the recent RSA Engineered Products ("RSA") acquisition, allowing the Company to better leverage the machining competencies and resources across its aerospace businesses. See Note 16, " Segment Information ," for further information on each of the Company's reportable segments. In addition, on December 20, 2019, the Company completed the sale of its Lamons division (“Lamons”), a transaction entered into with an investment fund sponsored by First Reserve on November 1, 2019. Lamons was sold for approximately $135 million in cash. The financial results of Lamons were previously reported within the Company's Specialty Products segment, and are presented as discontinued operations for all periods presented in the financial statements attached hereto. See Note 3, " Discontinued Operations ," for further information on the sale of Lamons and its historical financial results. The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries and, in the opinion of management, contain all adjustments, including adjustments of a normal and recurring nature, necessary for a fair presentation of financial position and results of operations. The preparation of financial statements also requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities. Actual results may differ from such estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the ongoing outbreak of a new strain of the coronavirus (“COVID-19”). While the full impact of COVID-19 is unknown and cannot be reasonably estimated at this time, the Company has made appropriate accounting estimates based on the facts and circumstances available as of the reporting date. To the extent there are differences between these estimates and actual results, the Company's consolidated financial statements may be materially affected. Results of operations for interim periods are not necessarily indicative of results for the full year, and certain prior year amounts have been reclassified to conform to current year presentation. The accompanying consolidated financial statements and notes thereto should be read in conjunction with the Company's 2019 Annual Report on Form 10-K.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 30, 2020
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Recently Issued Accounting Pronouncements In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" ("ASU 2019-12"), which removes specific exceptions to the general principles in Topic 740, simplifies the accounting for income taxes and provides clarification of certain aspects of current guidance. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. The Company is in the process of assessing the impact of adoption on its consolidated financial statements. In August 2018, the FASB issued ASU 2018-14, "Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20)" ("ASU 2018-14"), which modifies the disclosure requirements for employers who sponsor defined benefit pension or other postretirement plans. ASU 2018-14 is effective for fiscal years ending after December 15, 2020, with early adoption permitted. ASU 2018-14 is to be applied retrospectively to all periods presented. The Company is in the process of assessing the impact of adoption on its consolidated financial statements. Recently Adopted Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment" ("ASU 2017-04"), which simplifies the test for goodwill impairment by eliminating the requirement to perform a hypothetical purchase price allocation to measure the amount of goodwill impairment. Instead, under ASU 2017-04, the goodwill impairment is the amount by which a reporting unit's carrying value exceeds its fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The Company adopted ASU 2017-04 on January 1, 2020. See Note 8, "Goodwill and Other Intangible Assets,"

Discontinued Operations Discont

Discontinued Operations Discontinued Operations	9 Months Ended
	Sep. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	Discontinued Operations On December 20, 2019, the Company completed the sale of Lamons to two wholly-owned subsidiaries of an investment fund sponsored by First Reserve, pursuant to an Asset and Stock Purchase Agreement dated as of November 1, 2019 (the “Purchase Agreement”), for a purchase price of $135 million, subject to certain adjustments as set forth in the Purchase Agreement. The purchase price was finalized in the first quarter of 2020 and resulted in a $1.8 million payment to the Company. The Company's historical results for Lamons are shown in the accompanying consolidated statement of operations as a discontinued operation. Results of discontinued operations are summarized as follows (dollars in thousands): Three months ended Nine months ended 2019 2019 Net sales $ 48,420 $ 144,880 Cost of sales (36,170) (108,040) Gross profit 12,250 36,840 Selling, general and administrative expenses (7,130) (21,620) Operating profit 5,120 15,220 Other income, net 10 30 Income from discontinued operations, before income taxes 5,130 15,250 Income tax expense (1,260) (3,540) Income from discontinued operations, net of tax $ 3,870 $ 11,710

Revenue Revenue (Notes)

Revenue Revenue (Notes)	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	Revenue The following table presents the Company’s disaggregated net sales by primary market served (dollars in thousands): Three months ended September 30, Nine months ended September 30, Customer Markets 2020 2019 2020 2019 Consumer Products $ 114,220 $ 82,500 $ 298,060 $ 233,250 Aerospace & Defense 39,130 50,560 130,670 145,650 Industrial 46,110 55,350 153,070 173,710 Total net sales $ 199,460 $ 188,410 $ 581,800 $ 552,610

Realignment Actions Realignment

Realignment Actions Realignment Actions (Notes)	9 Months Ended
	Sep. 30, 2020
Realignment Actions [Abstract]
Restructuring, Impairment, and Other Activities Disclosure [Text Block]	Realignment ActionsIn the three and nine months ended September 30, 2020, the Company executed certain realignment actions, primarily in its Aerospace and Specialty Products segments, in response to reductions in current and expected future end market demand. During the nine months ended September 30, 2020, the Company recorded a non-cash charge of approximately $13.2 million related to inventory reductions, primarily as a result of a strategic decision in its Arrow Engine division to narrow its product line focus. During the three and nine months ended September 30, 2020, the Company also recorded non-cash charges of approximately $0.1 million and $2.3 million, respectively, related to certain production equipment removed from service given reduced demand levels. In addition, the Company reduced its employment levels given lower customer demand incurring approximately $0.5 million and $3.6 million during the three and nine months ended September 30, 2020, respectively, in severance charges, of which approximately $2.9 million was paid by September 30, 2020. For the three and nine months ended September 30, 2020, approximately $0.4 million and $16.4 million of these charges were included in cost of sales, respectively, and approximately $0.2 million and $2.7 million were included in selling, general and administrative expenses, respectively, in the accompanying consolidated statement of operations.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	Acquisitions 2020 Acquisitions On April 17, 2020, the Company acquired the Rapak ® brand, including certain bag-in-box product lines and assets ("Rapak") for an aggregate amount of approximately $11.4 million, subject to normal course adjustments. Rapak, which is reported in the Company's Packaging segment, has manufacturing locations in Indiana, California and Illinois, and historically generated approximately $30 million in annual revenue. On February 27, 2020, the Company acquired RSA Engineered Products, a manufacturer of complex, highly-engineered and proprietary ducting, connectors and related products for air management systems used in aerospace and defense applications, for an aggregate amount of approximately $83.7 million, net of cash acquired, subject to normal course adjustments. The fair value of assets acquired and liabilities assumed included approximately $80.2 million of goodwill and intangible assets, $10.1 million of net working capital, $2.1 million of property and equipment, and $8.7 million of net deferred tax liabilities. RSA, which is reported in the Company's Aerospace segment, is located in Simi Valley, California and historically generated approximately $30 million in annual revenue. In connection with the acquisitions, the Company recorded approximately $2.8 million of non-cash purchase accounting-related expenses during the nine months ended September 30, 2020 within cost of sales related to the step-up in value and subsequent sale of inventory. 2019 Acquisitions In April 2019, the Company acquired Taplast S.p.A. ("Taplast"), a designer and manufacturer of dispensers, closures and containers for the beauty and personal care, home care, and food and beverage packaging markets, for an aggregate amount of approximately $44.7 million, net of cash acquired. With manufacturing locations in both Italy and Slovakia, Taplast serves markets in Europe and North America and historically generated approximately $32 million in annual revenue. Taplast is reported in the Company's Packaging segment. In January 2019, the Company acquired Plastic Srl, a manufacturer of single-bodied and assembled polymeric caps and closures for use in home care products, for an aggregate amount of approximately $22.4 million, net of cash acquired. Located in Italy, Plastic Srl serves the home care market throughout Italy and other European countries and historically generated approximately $12 million in annual revenue. Plastic Srl is reported in the Company's Packaging segment. In connection with the acquisitions, the Company recorded approximately $1.2 million of non-cash purchase accounting-related expenses during the nine months ended September 30, 2019, of which approximately $0.9 million was recognized within selling, general and administrative expenses, primarily related to the write-off of the Plastic Srl trade name acquired that will not be used. In addition, approximately $0.3 million was recognized during the nine months ended September 30, 2019, within cost of sales related to the step-up in value and subsequent sale of inventory.

Cash and Cash Equivalents

Cash and Cash Equivalents	9 Months Ended
	Sep. 30, 2020
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents Disclosure	Cash and Cash Equivalents Cash and cash equivalents consists of the following components (dollars in thousands): September 30, December 31, Cash and cash equivalents - unrestricted $ 89,200 $ 172,470 Cash - restricted 10,540 — Total cash and cash equivalents $ 99,740 $ 172,470 As of September 30, 2020, the Company placed cash on deposit with a financial institution to be held as cash collateral for the Company's outstanding letters of credit. Prior to the third quarter of 2020, the Company used a portion of its credit agreement as collateral for letters of credit, which decreased availability under its revolving credit facility. See Note 11, "Long-term Debt,"

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The Company assesses goodwill and other intangible assets for impairment on an annual basis as of October 1, and more frequently if there are changes in the business climate or as a result of a triggering event taking place. During the third quarter of 2020, as a result of a decline in its aerospace-related business' financial results, a significant reduction in its financial projections for the remainder of 2020 compared with prior projections, and uncertainty around the duration and magnitude of the impact of the COVID-19 pandemic on future financial results given their dependence on future levels of air travel and new aircraft builds, the Company determined there was a triggering event requiring an interim quantitative goodwill impairment assessment of each of its two aerospace-related reporting units: Aerospace Fasteners and Aerospace Engineered Products. In preparing the quantitative analysis, the Company utilized both income and market-based approaches. The income-based approach was conducted using the discounted cash flow method, for which management updated its internal five-year forecast, and reflected its current best estimates of when, and at what level, a recovery of air travel, new aircraft builds, and resulting customer orders would occur and the related impact on each reporting unit's future sales, earnings and cash flows. Assumptions in estimating the future cash flows were based on Level 3 inputs under the fair value hierarchy. The Company also selected appropriate terminal growth rates as well as discount rates, which considered various factors including the level of inherent risk in achieving the forecast based on prior history and current market conditions. The market-based approach considered potentially comparable publicly traded companies and transactions within the aerospace industry and applied their trading multiples to management's forecast estimates. Upon completion of the quantitative goodwill impairment tests, the Company determined that the carrying values of the Aerospace Fasteners and Aerospace Engineered Products reporting units exceeded their fair values, resulting goodwill impairment charges of approximately $70.8 million in its Aerospace Fasteners reporting unit and approximately $56.0 million in its Aerospace Engineered Products reporting unit during the three and nine month periods ended September 30, 2020. Following the impairment charges, the Aerospace Fasteners reporting unit has $62.9 million of remaining goodwill, while the Aerospace Engineered Products reporting unit has no remaining goodwill. The Company notes that a 1% change in the discount rate would have impacted the total goodwill impairment charge by approximately $20 million, while a 0.5% change in the terminal growth rate would have impacted the total goodwill impairment charge by approximately $5 million. If the future financial results of the aerospace-related businesses significantly differ from the assumptions inherent in this analysis, the Company may be subject to further impairment charges. In the first quarter of 2020, the Company began reporting its machined components operations within the Aerospace segment. These operations were previously reported in the Company's Specialty Products segment. As a result of the reporting structure change, goodwill of approximately $12.7 million was reassigned from the Specialty Products segment to the Aerospace segment. Changes in the carrying amount of goodwill for the nine months ended September 30, 2020 are summarized as follows (dollars in thousands): Packaging Aerospace Specialty Products Total Balance, December 31, 2019 $ 181,650 $ 133,690 $ 19,300 $ 334,640 Goodwill from acquisitions — 43,260 — 43,260 Goodwill reassigned in segment realignment — 12,740 (12,740) — Impairment charge — (126,840) — (126,840) Foreign currency translation and other 810 — — 810 Balance, September 30, 2020 $ 182,460 $ 62,850 $ 6,560 $ 251,870 Other Intangible Assets As a result of the significant forecast reduction in the Company's aerospace-related businesses, the Company also performed an interim quantitative assessment for the indefinite-lived intangible assets within the Aerospace segment, using the relief-from-royalty method. Significant management assumptions used under the relief-from-royalty method reflected the Company's current assessment of the risks and uncertainties associated with the aerospace industry. Upon completion of the quantitative impairment test, the Company determined that certain of the Company's aerospace-related trade names had carrying values that exceeded their fair values, and therefore recorded impairment charges of approximately $7.8 million during the three and nine month periods ended September 30, 2020. The Company amortizes its other intangible assets over periods ranging from one to 30 years. The gross carrying amounts and accumulated amortization of the Company's other intangibles are summarized below (dollars in thousands): As of September 30, 2020 As of December 31, 2019 Intangible Category by Useful Life Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Finite-lived intangible assets: Customer relationships, 5 – 12 years $ 100,610 $ (56,810) $ 73,860 $ (49,910) Customer relationships, 15 – 25 years 122,270 (60,840) 122,280 (56,010) Total customer relationships 222,880 (117,650) 196,140 (105,920) Technology and other, 1 – 15 years 54,110 (32,020) 52,430 (29,790) Technology and other, 17 – 30 years 43,300 (39,090) 43,300 (37,620) Total technology and other 97,410 (71,110) 95,730 (67,410) Indefinite-lived intangible assets: Trademark/Trade names 44,060 — 42,850 — Total other intangible assets $ 364,350 $ (188,760) $ 334,720 $ (173,330) Amortization expense related to intangible assets as included in the accompanying consolidated statement of operations is summarized as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Technology and other, included in cost of sales $ 1,240 $ 1,190 $ 3,710 $ 3,590 Customer relationships, included in selling, general and administrative expenses 4,070 3,460 11,750 10,440 Total amortization expense $ 5,310 $ 4,650 $ 15,460 $ 14,030

Inventories

Inventories	9 Months Ended
	Sep. 30, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consist of the following components (dollars in thousands): September 30, December 31, Finished goods $ 74,440 $ 68,350 Work in process 29,640 30,560 Raw materials 38,520 33,750 Total inventories $ 142,600 $ 132,660

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment consists of the following components (dollars in thousands): September 30, December 31, Land and land improvements $ 19,800 $ 19,110 Buildings 87,540 84,880 Machinery and equipment 342,690 326,990 450,030 430,980 Less: Accumulated depreciation 234,400 216,650 Property and equipment, net $ 215,630 $ 214,330 Depreciation expense as included in the accompanying consolidated statement of operations is as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Depreciation expense, included in cost of sales $ 6,680 $ 6,040 $ 20,870 $ 17,480 Depreciation expense, included in selling, general and administrative expenses 250 300 830 850 Total depreciation expense $ 6,930 $ 6,340 $ 21,700 $ 18,330

Long-term Debt

Long-term Debt	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Long-term debt	Long-term Debt The Company's long-term debt consists of the following (dollars in thousands): September 30, December 31, 4.875% Senior Notes due October 2025 $ 300,000 $ 300,000 Debt issuance costs (4,450) (5,310) Long-term debt, net $ 295,550 $ 294,690 Senior Notes In September 2017, the Company issued $300.0 million aggregate principal amount of 4.875% senior notes due October 15, 2025 ("Senior Notes") at par value in a private placement under Rule 144A of the Securities Act of 1933, as amended. The Senior Notes accrue interest at a rate of 4.875% per annum, payable semi-annually in arrears on April 15 and October 15. The payment of principal and interest is jointly and severally guaranteed, on a senior unsecured basis, by certain subsidiaries of the Company (each a "Guarantor" and collectively the "Guarantors"). The Senior Notes are pari passu in right of payment with all existing and future senior indebtedness and subordinated to all existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness. Prior to October 15, 2020, the Company may redeem up to 35% of the principal amount of the Senior Notes at a redemption price of 104.875% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, with the net cash proceeds of one or more equity offerings provided that each such redemption occurs within 90 days of the date of closing of each such equity offering. In addition, the Company may redeem all or part of the Senior Notes at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date, plus a "make whole" premium. On or after October 15, 2020, the Company may redeem all or part of the Senior Notes at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid interest, if any, to the redemption date, if redeemed during the twelve-month period beginning on October 15 of the years indicated below: Year Percentage 2020 102.438 % 2021 101.219 % 2022 and thereafter 100.000 % Credit Agreement The Company is a party to a credit agreement ("Credit Agreement") consisting of a $300.0 million senior secured revolving credit facility, which permits borrowings denominated in specific foreign currencies, subject to a $125.0 million sub limit, matures on September 20, 2022 and is subject to interest at London Interbank Offered Rate ("LIBOR") plus 1.50%. The interest rate spread is based upon the leverage ratio, as defined, as of the most recent determination date. The Credit Agreement also provides incremental revolving credit facility commitments in an amount not to exceed the greater of $200.0 million and an amount such that, after giving effect to such incremental commitments and the incurrence of any other indebtedness substantially simultaneously with the making of such commitments, the senior secured net leverage ratio, as defined, is no greater than 3.00 to 1.00. The terms and conditions of any incremental revolving credit facility commitments must be no more favorable than the existing credit facility. The Company's revolving credit facility allows for the issuance of letters of credit, not to exceed $40.0 million in aggregate. During the three months ended September 30, 2020, the Company placed cash on deposit with a financial institution to be held as cash collateral for the Company's outstanding letters of credit; therefore, as of September 30, 2020 the Company had no letters of credit issued against its revolving credit facility. See Note 7, "Cash and Cash Equivalents," for further information on its cash deposit. At September 30, 2020, the Company had no amounts outstanding under its revolving credit facility and had $300.0 million potentially available after giving effect to letters of credit issued and outstanding. At December 31, 2019, the Company had no amounts outstanding under its revolving credit facility and had approximately $283.9 million potentially available after giving effect to approximately $16.1 million of letters of credit issued and outstanding. The Company's borrowing capacity was not reduced by leverage restrictions contained in the Credit Agreement as of September 30, 2020 and December 31, 2019. The Company previously drew $150 million on its revolving credit facility in March 2020 to defend against potential uncertainty or liquidity issues in the financial markets as a result of the COVID-19 pandemic, but repaid this amount during second quarter 2020. The debt under the Credit Agreement is an obligation of the Company and certain of its domestic subsidiaries and is secured by substantially all of the assets of such parties. Borrowings under the $125.0 million (equivalent) foreign currency sub limit of the $300.0 million senior secured revolving credit facility are secured by a cross-guarantee amongst, and a pledge of the assets of, the foreign subsidiary borrowers that are a party to the agreement. The Credit Agreement also contains various negative and affirmative covenants and other requirements affecting the Company and its subsidiaries, including the ability, subject to certain exceptions and limitations, to incur debt, liens, mergers, investments, loans, advances, guarantee obligations, acquisitions, assets dispositions, sale-leaseback transactions, hedging agreements, dividends and other restricted payments, transactions with affiliates, restrictive agreements and amendments to charters, bylaws, and other material documents. The terms of the Credit Agreement also require the Company and its restricted subsidiaries to meet certain restrictive financial covenants and ratios computed quarterly, including a maximum total net leverage ratio (total consolidated indebtedness plus outstanding amounts under the accounts receivable securitization facility, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined), a maximum senior secured net leverage ratio (total consolidated senior secured indebtedness, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined) and a minimum interest expense coverage ratio (consolidated EBITDA, as defined, over the sum of consolidated cash interest expense, as defined, and preferred dividends, as defined). At September 30, 2020, the Company was in compliance with its financial covenants contained in the Credit Agreement. Fair Value of Debt The valuations of the Senior Notes and other debt were determined based on Level 2 inputs under the fair value hierarchy, as defined. The carrying amounts and fair values were as follows (dollars in thousands): September 30, 2020 December 31, 2019 Carrying Amount Fair Value Carrying Amount Fair Value Senior Notes $ 300,000 $ 303,000 $ 300,000 $ 309,000

Derivative Instruments

Derivative Instruments	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Derivatives Designated as Hedging Instruments In October 2018, the Company entered into cross-currency swap agreements to hedge its net investment in Euro-denominated assets against future volatility in the exchange rate between the U.S. dollar and the Euro. By doing so, the Company synthetically converted a portion of its U.S. dollar-based long-term debt into Euro-denominated long-term debt. The agreements have a five year tenor at notional amounts declining from $125.0 million to $75.0 million over the contract period. Under the terms of the swap agreements, the Company is to receive net interest payments at a fixed rate of approximately 2.9% of the notional amount. At inception, the cross-currency swaps were designated as net investment hedges. As of September 30, 2020 and December 31, 2019, the fair value carrying amount of the Company's derivative instruments are recorded as follows (dollars in thousands): Asset / (Liability) Derivatives Derivatives designated as hedging instruments Balance Sheet Caption September 30, December 31, Net Investment Hedges Cross-currency swaps Other assets $ 1,490 $ 4,460 The following table summarizes the income recognized in accumulated other comprehensive income (loss) ("AOCI") on derivative contracts designated as hedging instruments as of September 30, 2020 and December 31, 2019, and the amounts reclassified from AOCI into earnings for the three and nine months ended September 30, 2020 and 2019 (dollars in thousands): Amount of Income Recognized Amount of Income (Loss) Reclassified Three months ended Nine months ended As of As of December 31, 2019 Location of Income (Loss) Reclassified from AOCI into Earnings (Effective Portion) 2020 2019 2020 2019 Net Investment Hedges Cross-currency swaps $ 1,950 $ 4,230 Other income, net $ — $ — $ — $ — Over the next 12 months, the Company does not expect to reclassify any pre-tax deferred amounts from AOCI into earnings. Derivatives Not Designated as Hedging Instruments As of September 30, 2020, the Company was party to foreign currency exchange forward contracts to economically hedge changes in foreign currency rates with notional amounts of approximately $63.5 million. The Company uses foreign exchange contracts to mitigate the risk associated with fluctuations in currency rates impacting cash flows related to certain of its receivables, payables and intercompany transactions denominated in foreign currencies. The foreign exchange contracts primarily mitigate currency exposures between the U.S. dollar and the Euro, British pound, Mexican peso and the Chinese yuan, and have various settlement dates through December 2020. These contracts are not designated as hedge instruments; therefore, gains and losses on these contracts are recognized each period directly into the consolidated statement of operations. The following table summarizes the effects of derivatives not designated as hedging instruments on the Company's consolidated statement of operations (dollars in thousands): Amount of Income Recognized in Three months ended Nine months ended Location of Income 2020 2019 2020 2019 Derivatives not designated as hedging instruments Foreign exchange contracts Other income, net $ 800 $ 1,170 $ 1,280 $ 1,390 Fair Value of Derivatives The fair value of the Company's derivatives are estimated using an income approach based on valuation techniques to convert future amounts to a single, discounted amount. Estimates of the fair value of the Company's cross-currency swaps and foreign exchange contracts use observable inputs such as interest rate yield curves and forward currency exchange rates. Fair value measurements and the fair value hierarchy level for the Company's assets and liabilities measured at fair value on a recurring basis as of September 30, 2020 and December 31, 2019 are shown below (dollars in thousands): Description Frequency Asset / (Liability) Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs September 30, 2020 Cross-currency swaps Recurring $ 1,490 $ — $ 1,490 $ — Foreign exchange contracts Recurring $ (350) $ — $ (350) $ — December 31, 2019 Cross-currency swaps Recurring $ 4,460 $ — $ 4,460 $ — Foreign exchange contracts Recurring $ (770) $ — $ (770) $ —

Leases Leases (Notes)

Leases Leases (Notes)	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Leases	Leases The Company leases certain equipment and facilities under non-cancelable operating leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet; expense related to these leases is recognized on a straight-line basis over the lease term. The components of lease expense are as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Operating lease cost $ 2,110 $ 1,610 $ 5,780 $ 4,750 Short-term, variable and other lease costs 410 230 990 640 Total lease cost $ 2,520 $ 1,840 $ 6,770 $ 5,390 Maturities of lease liabilities are as follows (dollars in thousands): Year ended December 31, Operating Leases (a) 2020 (excluding the nine months ended September 30, 2020) $ 2,080 2021 7,680 2022 6,900 2023 5,940 2024 4,730 Thereafter 14,590 Total lease payments 41,920 Less: Imputed interest (5,330) Present value of lease liabilities $ 36,590 __________________________ (a) The maturity table excludes cash flows associated with exited lease facilities. Liabilities for exited lease facilities are included in accrued liabilities and other long-term liabilities in the accompanying consolidated balance sheet. The weighted-average remaining lease term of the Company's operating leases as of September 30, 2020 is approximately 6.6 years. The weighted-average discount rate as of September 30, 2020 is approximately 4.5%. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $5.4 million and $4.9 million during the nine months ended September 30, 2020 and 2019, respectively, and is included in cash flows provided by operating activities in the consolidated statement of cash flows. Right-of-use assets obtained in exchange for lease liabilities were approximately $10.5 million, primarily due to the acquisitions of RSA and Rapak, and $0.9 million during the nine months ended September 30, 2020 and 2019, respectively.

Other Long-term Liabilities Oth

Other Long-term Liabilities Other Long-term Liabilities (Notes)	9 Months Ended
	Sep. 30, 2020
Other Liabilities Disclosure [Abstract]
Other Liabilities Disclosure [Text Block]	Other long-term liabilities Other long-term liabilities consist of the following components (dollars in thousands): September 30, December 31, Non-current asbestos-related liabilities $ 26,840 $ 6,200 Other long-term liabilities 30,410 34,610 Total other long-term liabilities $ 57,250 $ 40,810

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Asbestos As of September 30, 2020, the Company was a party to 374 pending cases involving an aggregate of 4,693 claims primarily alleging personal injury from exposure to asbestos containing materials formerly used in gaskets (both encapsulated and otherwise) manufactured or distributed by Lamons and certain other related subsidiaries for use primarily in the petrochemical, refining and exploration industries. The following chart summarizes the number of claims, number of claims filed, number of claims dismissed, number of claims settled, the average settlement amount per claim and the total defense costs, at the applicable date and for the applicable periods: Claims Claims filed Claims Claims Claims Average Total defense Nine Months Ended September 30, 2020 4,759 159 214 11 4,693 $ 48,864 $ 1,580,000 Fiscal Year Ended December 31, 2019 4,820 143 172 32 4,759 $ 16,616 $ 2,250,000 In addition, the Company acquired various companies to distribute its products that had distributed gaskets of other manufacturers prior to acquisition. The Company believes that many of its pending cases relate to locations at which none of its gaskets were distributed or used. The Company may be subjected to significant additional asbestos-related claims in the future, and will aggressively defend or reasonably resolve, as appropriate. The cost of settling cases in which product identification can be made may increase, and the Company may be subjected to further claims in respect of the former activities of its acquired gasket distributors. The cost of claims varies as claims may be initially made in some jurisdictions without specifying the amount sought or by simply stating the requisite or maximum permissible monetary relief, and may be amended to alter the amount sought. The large majority of claims do not specify the amount sought. Of the 4,693 claims pending at September 30, 2020, 56 set forth specific amounts of damages (other than those stating the statutory minimum or maximum). At September 30, 2020, of the 56 claims that set forth specific amounts, there were no claims seeking specific amounts for punitive damages. Below is a breakdown of the compensatory damages sought for those claims seeking specific amounts: Compensatory Range of damages sought (dollars in millions) $0.0 to $0.6 $0.6 to $5.0 $5.0+ Number of claims — 10 46 Relatively few claims have reached the discovery stage and even fewer claims have gone past the discovery stage. Total settlement costs (exclusive of defense costs) for all such cases, some of which were filed over 25 years ago, have been approximately $9.9 million. All relief sought in the asbestos cases is monetary in nature. Based on the settlements made to date and the number of claims dismissed or withdrawn for lack of product identification, the Company believes that the relief sought (when specified) does not bear a reasonable relationship to its potential liability. There has been significant volatility in the historical number of claim filings and costs to defend, with previous claim counts and spend levels much higher than current levels. Management believes this volatility was associated more with tort reform, plaintiff practices and state-specific legal dockets than the Company’s underlying asbestos-related exposures. In the past three years, however, the number of new claim filings, and costs to defend, have become much more consistent, ranging between 143 to 173 new claims per year and total defense costs ranging between $2.2 million and $2.3 million. The higher degree of consistency in census data and spend levels, as well as lower claim activity levels and an evolving defense strategy, has allowed the Company to more effectively and efficiently manage claims, making process or local counsel arrangement improvements where possible. Given the consistency of activity over a multi-year period, the Company believed a trend may have formed where it could be possible to reasonably estimate its future cash exposure for all asbestos-related activity with an adequate level of precision. As such, the Company commissioned an actuary to help evaluate the nature and predictability of its asbestos-related costs, and provide an actuarial range of estimates of future exposures. Based upon its review of the actuarial study, which was completed in June 2020 using data as of December 31, 2019 and which projected spend levels through a terminal year of 2064, the Company affirmed its belief that it now has the ability to reasonably estimate its future asbestos-related exposures for pending as well as unknown future claims. During the second quarter 2020, the Company elected to change its method of accounting for asbestos-related defense costs from accruing for probable and reasonably estimable defense costs associated with known claims expected to settle to accrue for all future defense costs for both known and unknown claims, which the Company now believes are reasonably estimable. The Company believes this change is preferable, as asbestos-related defense costs represent expenditures related to legacy activities that do not contribute to current or future revenue generating activities, and recording an estimate of the full liability for asbestos-related costs, where estimable with reasonable precision, provides a more complete assessment of the liability associated with resolving asbestos-related claims. This accounting change has been reflected as a change in accounting estimate effected by a change in accounting principle. In connection with this second quarter 2020 change, the Company recorded a non-cash, pre-tax charge for asbestos-related costs of approximately $23.4 million, which is included in selling, general and administrative expenses in the accompanying consolidated statement of operations. Following the change in accounting estimate, the Company’s liability for asbestos-related claims will be based on a study from the Company’s third-party actuary, the Company's review of the study, as well as the Company’s own review of asbestos claims and claim resolution activity. The study from the Company’s actuary, based on data as of December 31, 2019, provided for a range of possible future liability from $31.5 million to $43.3 million. The Company did not believe any amount within the range of potential outcomes represented a better estimate than another given the many factors and assumptions inherent in the projections, and therefore recorded the $23.4 million charge to increase the liability estimate to $31.5 million, at the low-end of the range. As of September 30, 2020, the Company’s total asbestos-related liability is $29.4 million, and is included in accrued liabilities and other long-term liabilities, respectively, in the accompanying consolidated balance sheet. The Company’s primary insurance, which covered approximately 40% of historical costs related to settlement and defense of asbestos litigation, expired in November 2018, upon which the Company became solely responsible for defense costs and indemnity payments. The Company is party to a coverage-in-place agreement (entered into in 2006) with its first level excess carriers regarding the coverage to be provided to the Company for asbestos-related claims. The coverage-in-place agreement makes asbestos defense costs and indemnity insurance coverage available to the Company that might otherwise be disputed by the carriers and provides a methodology for the administration of such expenses. The Company will continue to be solely responsible for defense costs and indemnity payments prior to the commencement of coverage under this agreement, the duration of which would be subject to the scope of damage awards and settlements paid. Based upon the Company’s review of the actuarial study, the Company does not believe it is probable that it will reach the threshold of qualified future settlements required to commence excess carrier insurance coverage under the coverage-in-place agreement. While the Company recorded a significant non-cash charge in the six months ended June 30, 2020 in connection with its change in accounting policy, based upon the Company's experience to date, including the trend in annual defense and settlement costs incurred to date, and other available information (including the availability of excess insurance), the Company does not believe these cases will have a material adverse effect on its financial position or cash flows. Claims and Litigation The Company is subject to other claims and litigation in the ordinary course of business, but does not believe that any such claim or litigation will have a material adverse effect on its financial position and results of operations or cash flows.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Segment Information	Segment Information TriMas reports its operations in three segments: Packaging, Aerospace, and Specialty Products. Each of these segments has discrete financial information that is regularly evaluated by TriMas' president and chief executive officer (chief operating decision maker) in determining resource, personnel and capital allocation, as well as assessing strategy and performance. The Company utilizes its proprietary TriMas Business Model as its platform which is based upon a standardized set of processes to manage and drive results and strategy across its multi-industry businesses. Within each of the Company's reportable segments, there are no individual products or product families for which reported net sales accounted for more than 10% of the Company's consolidated net sales. See below for more information regarding the types of products and services provided within each reportable segment: Packaging – The Packaging segment, which consists primarily of the Rieke ® , Taplast, Stolz and Rapak® brands, develops and manufactures a broad array of dispensing products (such as foaming pumps, lotion and hand soap pumps, sanitizer pumps, beverage dispensers, perfume sprayers, nasal sprayers and trigger sprayers), polymeric and steel caps and closures (such as food lids, flip-top closures, child resistance caps, drum and pail closures and flexible spouts), polymeric jar products, and fully integrated dispensers for fill-ready bag-in-box applications, all for a variety of consumer products submarkets including, but not limited to, beauty and personal care, home care, food and beverage, and pharmaceutical and nutraceutical, as well as the industrial market. Aerospace – The Aerospace segment, which includes the Monogram Aerospace Fasteners ™ , Allfast Fastening Systems ® , Mac Fasteners ™ , RSA Engineered Products and Martinic Engineering ™ brands, develops, qualifies and manufactures highly-engineered, precision fasteners, tubular products and assemblies for fluid conveyance, and machined products and assemblies to serve the aerospace and defense market. Specialty Products – The Specialty Products segment, which includes the Norris Cylinder ™ and Arrow ® Engine brands, designs, manufactures and distributes highly-engineered steel cylinders, wellhead engines and compression systems for use within industrial markets. Segment activity is as follows (dollars in thousands): Three months ended Nine months ended 2020 2019 2020 2019 Net Sales Packaging $ 135,120 $ 105,480 $ 364,000 $ 298,310 Aerospace 39,130 50,560 130,660 145,650 Specialty Products 25,210 32,370 87,140 108,650 Total $ 199,460 $ 188,410 $ 581,800 $ 552,610 Operating Profit (Loss) Packaging $ 28,020 $ 19,740 $ 70,340 $ 60,020 Aerospace (133,500) 7,810 (132,630) 21,270 Specialty Products 3,380 3,620 870 13,730 Corporate (6,220) (7,600) (45,220) (24,590) Total $ (108,320) $ 23,570 $ (106,640) $ 70,430

Equity Awards

Equity Awards	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Equity Awards	Equity Awards Stock Options The Company did not grant any stock option awards during the nine months ended September 30, 2020. Information related to stock options at September 30, 2020 is as follows: Number of Weighted Average Option Price Average Remaining Contractual Life (Years) Aggregate Intrinsic Value Outstanding at January 1, 2020 150,000 $ 17.87 Granted — — Exercised — — Cancelled — — Expired — — Outstanding at September 30, 2020 150,000 $ 17.87 5.8 $ 739,500 As of September 30, 2020, the 150,000 stock options outstanding were exercisable under the Company's long-term equity incentive plans. As of September 30, 2020, there was no unrecognized compensation cost related to stock options remaining. The Company recognized no stock-based compensation expense related to stock options during the three and nine months ended September 30, 2020 and approximately $0.1 million of stock-based compensation expense during the three and nine months ended September 30, 2019. The stock-based compensation expense is included in selling, general and administrative expenses in the accompanying consolidated statement of operations. Restricted Stock Units The Company awarded the following restricted stock units ("RSUs") during the nine months ended September 30, 2020: • granted 189,349 RSUs to certain employees, which are subject only to a service condition and vest ratably over three years so long as the employee remains with the Company; • granted 31,816 RSUs to certain employees, which are subject only to a service condition and fully vest at the end of three years so long as the employee remains with the Company; • granted 2,558 RSUs to certain employees, which are subject only to a service condition and fully vest one year from the date of grant so long as the employee remains with the Company; • granted 30,590 RSUs to its non-employee independent directors, which fully vest one year from date of grant so long as the director and/or Company does not terminate the director's service prior to the vesting date; and • issued 3,222 RSUs related to director fee deferrals during the nine months ended September 30, 2020 as certain of the Company's directors elected to defer all or a portion of their directors fees and to receive the amount in Company common stock at a future date. During 2020, the Company awarded 113,146 performance-based RSUs to certain Company key employees which vest three years from the grant date as long as the employee remains with the Company. These awards are earned 50% based upon the Company's achievement of an earnings per share compound annual growth rate ("EPS CAGR") metric over a period beginning January 1, 2020 and ending December 31, 2022. The remaining 50% of the awards are earned based on the Company's total shareholder return ("TSR") relative to the TSR of the common stock of a pre-defined industry peer-group, measured over the performance period. TSR is calculated as the Company's average closing stock price for the 20 trading days at the end of the performance period plus Company dividends, divided by the Company's average closing stock price for the 20 trading days prior to the start of the performance period. The Company estimates the grant-date fair value subject to a market condition using a Monte Carlo simulation model, using the following weighted average assumptions: risk-free rate of 0.56% and annualized volatility of 26.2%. Depending on the performance achieved for these two metrics, the amount of shares earned, if any, can vary for each metric from 0% of the target award to a maximum of 200% of the target award. In addition, the Company awarded 87,034 performance-based RSUs to certain Company key divisional employees which vest three years from the grant date as long as the employee remains with the Company. These awards are earned based upon the Company's stock price performance over the period from January 1, 2020 and ending December 31, 2022. The stock price achievement is calculated based on the Company's average closing stock price for each quarter end for the 20 trading days up to and including March 31, June 30, September 30, and December 31, 2022, respectively. The Company estimates the grant-date fair value subject to a market condition using a Monte Carlo simulation model, using the following weighted average assumptions: risk-free rate of 0.85% and annualized volatility of 25.2%. Depending on the performance achieved for this metric, the amount of shares earned if any, can vary from 0% of the target award to a maximum of 160% of the target award, although it automatically is earned at the target award level if the Company's stock price is equal to or greater than a specified stock price for either five consecutive trading days or 20 total trading days during the performance period. During 2017, the Company awarded performance-based RSUs to certain Company key employees which were earned based upon the Company's TSR relative to the TSR of the common stock of a pre-defined industry peer-group and measured over a period beginning January 1, 2017 and ending on December 31, 2019. Depending on the performance achieved, the amount of shares earned could vary from 0% of the target award to a maximum of 200% of the target award. The Company attained 127.4% of the target, resulting in an increase of 27,567 shares during the nine months ended September 30, 2020. Information related to RSUs at September 30, 2020 is as follows: Number of Unvested RSUs Weighted Average Grant Date Fair Value Average Remaining Contractual Life (Years) Aggregate Intrinsic Value Outstanding at January 1, 2020 622,528 $ 30.77 Granted 485,282 21.42 Vested (302,087) 27.88 Cancelled (17,207) 28.24 Outstanding at September 30, 2020 788,516 $ 26.46 1.5 $ 17,978,165 As of September 30, 2020, there was approximately $10.3 million of unrecognized compensation cost related to unvested RSUs that is expected to be recorded over a weighted average period of 2.1 years years.

Earnings per Share

Earnings per Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per Share Net income is divided by the weighted average number of common shares outstanding during the period to calculate basic earnings per share. For the three and nine months ended September 30, 2020, no restricted shares or stock options were included in the computation of net income (loss) per share because to do so would be anti-dilutive. The following table summarizes the dilutive effect of RSUs and options to purchase common stock for the three and nine months ended September 30, 2020 and 2019: Three months ended Nine months ended 2020 2019 2020 2019 Weighted average common shares—basic 43,457,704 45,175,244 43,707,331 45,448,711 Dilutive effect of restricted stock units — 179,418 — 229,003 Dilutive effect of stock options — 61,105 — 67,707 Weighted average common shares—diluted 43,457,704 45,415,767 43,707,331 45,745,421

Defined Benefit Plans

Defined Benefit Plans	9 Months Ended
	Sep. 30, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Defined Benefit Plans	Defined Benefit Plans Net periodic pension benefit costs for the Company's defined benefit pension plans cover certain foreign employees, union hourly employees and salaried employees. The components of net periodic pension cost are as follows (dollars in thousands): Pension Plans Three months ended Nine months ended 2020 2019 2020 2019 Service costs $ 320 $ 270 $ 950 $ 790 Interest costs 240 260 710 800 Expected return on plan assets (380) (350) (1,110) (1,050) Amortization of net loss 220 140 670 430 Net periodic benefit cost $ 400 $ 320 $ 1,220 $ 970 The service cost component of net periodic benefit cost is recorded in cost of goods sold and selling, general and administrative expenses, while non-service cost components are recorded in other income (expense), net in the accompanying consolidated statement of operations.

Other Comprehensive Income (Los

Other Comprehensive Income (Loss) Other Comprehensive Income (Loss) (Notes)	9 Months Ended
	Sep. 30, 2020
Other Comprehensive Income [Abstract]
Comprehensive Income (Loss) Note [Text Block]	Other Comprehensive Income (Loss) Changes in AOCI by component for the nine months ended September 30, 2020 are summarized as follows, net of tax (dollars in thousands): Defined Benefit Plans Derivative Instruments Foreign Currency Translation Total Balance, December 31, 2019 $ (9,930) $ 4,230 $ (300) $ (6,000) Net unrealized gains (losses) arising during the period (a) — (2,280) (1,210) (3,490) Less: Net realized losses reclassified to net income (b) (470) — — (470) Net current-period other comprehensive income (loss) 470 (2,280) (1,210) (3,020) Balance, September 30, 2020 $ (9,460) $ 1,950 $ (1,510) $ (9,020) __________________________ (a) Derivative instruments, net of income tax of approximately $0.7 million. See Note 12, " Derivative Instruments ," for further details. (b) Defined benefit plans, net of income tax of approximately $0.1 million. See Note 19, " Defined Benefit Plans ," for further details. Changes in AOCI by component for the nine months ended September 30, 2019 are summarized as follows, net of tax (dollars in thousands): Defined Benefit Plans Derivative Instruments Foreign Currency Translation Total Balance, December 31, 2018 $ (7,200) $ 940 $ (10,590) $ (16,850) Net unrealized gains (losses) arising during the period (a) — 5,750 (4,380) 1,370 Less: Net realized losses reclassified to net income (b) (300) — — (300) Net current-period other comprehensive income (loss) 300 5,750 (4,380) 1,670 Reclassification of stranded tax effects (1,260) (10) — (1,270) Balance, September 30, 2019 $ (8,160) $ 6,680 $ (14,970) $ (16,450) __________________________ (a) Derivative instruments, net of income tax of approximately $1.8 million. See Note 12, " Derivative Instruments ," for further details. (b) Defined benefit plans, net of income tax of approximately $0.1 million. See Note 19, " Defined Benefit Plans ," for further details.

Subsequent Event Subsequent Eve

Subsequent Event Subsequent Events (Notes)	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Subsequent EventsOn October 27, 2020, the Company signed an agreement to acquire Affaba & Ferrari Srl, which specializes in the design, development and manufacture of precision caps and closures for food & beverage and industrial product applications, for a purchase price of approximately €84 million. Affaba & Ferrari operates out of a highly automated manufacturing facility and support office located in Borgo San Giovanni, Italy. The transaction is expected to close before the end of 2020, at which time Affaba & Ferrari will become part of TriMas’ Packaging segment. Affaba & Ferrari generated approximately €35 million in revenue in 2019.

Discontinued Operations Disco_2

Discontinued Operations Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations [Table Text Block]	Results of discontinued operations are summarized as follows (dollars in thousands): Three months ended Nine months ended 2019 2019 Net sales $ 48,420 $ 144,880 Cost of sales (36,170) (108,040) Gross profit 12,250 36,840 Selling, general and administrative expenses (7,130) (21,620) Operating profit 5,120 15,220 Other income, net 10 30 Income from discontinued operations, before income taxes 5,130 15,250 Income tax expense (1,260) (3,540) Income from discontinued operations, net of tax $ 3,870 $ 11,710

Revenue Revenue (Tables)

Revenue Revenue (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	The following table presents the Company’s disaggregated net sales by primary market served (dollars in thousands): Three months ended September 30, Nine months ended September 30, Customer Markets 2020 2019 2020 2019 Consumer Products $ 114,220 $ 82,500 $ 298,060 $ 233,250 Aerospace & Defense 39,130 50,560 130,670 145,650 Industrial 46,110 55,350 153,070 173,710 Total net sales $ 199,460 $ 188,410 $ 581,800 $ 552,610

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	9 Months Ended
	Sep. 30, 2020
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	Cash and cash equivalents consists of the following components (dollars in thousands): September 30, December 31, Cash and cash equivalents - unrestricted $ 89,200 $ 172,470 Cash - restricted 10,540 — Total cash and cash equivalents $ 99,740 $ 172,470

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Changes in the carrying amount of goodwill for the nine months ended September 30, 2020 are summarized as follows (dollars in thousands): Packaging Aerospace Specialty Products Total Balance, December 31, 2019 $ 181,650 $ 133,690 $ 19,300 $ 334,640 Goodwill from acquisitions — 43,260 — 43,260 Goodwill reassigned in segment realignment — 12,740 (12,740) — Impairment charge — (126,840) — (126,840) Foreign currency translation and other 810 — — 810 Balance, September 30, 2020 $ 182,460 $ 62,850 $ 6,560 $ 251,870
Schedule of Intangible Assets (excluding Goodwill) by Major Class	The Company amortizes its other intangible assets over periods ranging from one to 30 years. The gross carrying amounts and accumulated amortization of the Company's other intangibles are summarized below (dollars in thousands): As of September 30, 2020 As of December 31, 2019 Intangible Category by Useful Life Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Finite-lived intangible assets: Customer relationships, 5 – 12 years $ 100,610 $ (56,810) $ 73,860 $ (49,910) Customer relationships, 15 – 25 years 122,270 (60,840) 122,280 (56,010) Total customer relationships 222,880 (117,650) 196,140 (105,920) Technology and other, 1 – 15 years 54,110 (32,020) 52,430 (29,790) Technology and other, 17 – 30 years 43,300 (39,090) 43,300 (37,620) Total technology and other 97,410 (71,110) 95,730 (67,410) Indefinite-lived intangible assets: Trademark/Trade names 44,060 — 42,850 — Total other intangible assets $ 364,350 $ (188,760) $ 334,720 $ (173,330)
Schedule of Finite-Lived Intangible Assets, Amortization Expense	Amortization expense related to intangible assets as included in the accompanying consolidated statement of operations is summarized as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Technology and other, included in cost of sales $ 1,240 $ 1,190 $ 3,710 $ 3,590 Customer relationships, included in selling, general and administrative expenses 4,070 3,460 11,750 10,440 Total amortization expense $ 5,310 $ 4,650 $ 15,460 $ 14,030

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories consist of the following components (dollars in thousands): September 30, December 31, Finished goods $ 74,440 $ 68,350 Work in process 29,640 30,560 Raw materials 38,520 33,750 Total inventories $ 142,600 $ 132,660

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment consists of the following components (dollars in thousands): September 30, December 31, Land and land improvements $ 19,800 $ 19,110 Buildings 87,540 84,880 Machinery and equipment 342,690 326,990 450,030 430,980 Less: Accumulated depreciation 234,400 216,650 Property and equipment, net $ 215,630 $ 214,330
Depreciation Expense	Depreciation expense as included in the accompanying consolidated statement of operations is as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Depreciation expense, included in cost of sales $ 6,680 $ 6,040 $ 20,870 $ 17,480 Depreciation expense, included in selling, general and administrative expenses 250 300 830 850 Total depreciation expense $ 6,930 $ 6,340 $ 21,700 $ 18,330

Long-term Debt Long-term Debt (

Long-term Debt Long-term Debt (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule of Debt	The Company's long-term debt consists of the following (dollars in thousands): September 30, December 31, 4.875% Senior Notes due October 2025 $ 300,000 $ 300,000 Debt issuance costs (4,450) (5,310) Long-term debt, net $ 295,550 $ 294,690 September 30, 2020 December 31, 2019 Carrying Amount Fair Value Carrying Amount Fair Value Senior Notes $ 300,000 $ 303,000 $ 300,000 $ 309,000
Debt Instrument Redemption [Table Text Block]	On or after October 15, 2020, the Company may redeem all or part of the Senior Notes at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid interest, if any, to the redemption date, if redeemed during the twelve-month period beginning on October 15 of the years indicated below: Year Percentage 2020 102.438 % 2021 101.219 % 2022 and thereafter 100.000 %

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	As of September 30, 2020 and December 31, 2019, the fair value carrying amount of the Company's derivative instruments are recorded as follows (dollars in thousands): Asset / (Liability) Derivatives Derivatives designated as hedging instruments Balance Sheet Caption September 30, December 31, Net Investment Hedges Cross-currency swaps Other assets $ 1,490 $ 4,460
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The following table summarizes the income recognized in accumulated other comprehensive income (loss) ("AOCI") on derivative contracts designated as hedging instruments as of September 30, 2020 and December 31, 2019, and the amounts reclassified from AOCI into earnings for the three and nine months ended September 30, 2020 and 2019 (dollars in thousands): Amount of Income Recognized Amount of Income (Loss) Reclassified Three months ended Nine months ended As of As of December 31, 2019 Location of Income (Loss) Reclassified from AOCI into Earnings (Effective Portion) 2020 2019 2020 2019 Net Investment Hedges Cross-currency swaps $ 1,950 $ 4,230 Other income, net $ — $ — $ — $ —
Derivatives Not Designated as Hedging Instruments	The following table summarizes the effects of derivatives not designated as hedging instruments on the Company's consolidated statement of operations (dollars in thousands): Amount of Income Recognized in Three months ended Nine months ended Location of Income 2020 2019 2020 2019 Derivatives not designated as hedging instruments Foreign exchange contracts Other income, net $ 800 $ 1,170 $ 1,280 $ 1,390
Fair Value Measurements, Recurring and Nonrecurring	air value measurements and the fair value hierarchy level for the Company's assets and liabilities measured at fair value on a recurring basis as of September 30, 2020 and December 31, 2019 are shown below (dollars in thousands): Description Frequency Asset / (Liability) Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs September 30, 2020 Cross-currency swaps Recurring $ 1,490 $ — $ 1,490 $ — Foreign exchange contracts Recurring $ (350) $ — $ (350) $ — December 31, 2019 Cross-currency swaps Recurring $ 4,460 $ — $ 4,460 $ — Foreign exchange contracts Recurring $ (770) $ — $ (770) $ —

Leases Leases (Tables)

Leases Leases (Tables)	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Lease, Cost [Table Text Block]	The components of lease expense are as follows (dollars in thousands): Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Operating lease cost $ 2,110 $ 1,610 $ 5,780 $ 4,750 Short-term, variable and other lease costs 410 230 990 640 Total lease cost $ 2,520 $ 1,840 $ 6,770 $ 5,390
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Maturities of lease liabilities are as follows (dollars in thousands): Year ended December 31, Operating Leases (a) 2020 (excluding the nine months ended September 30, 2020) $ 2,080 2021 7,680 2022 6,900 2023 5,940 2024 4,730 Thereafter 14,590 Total lease payments 41,920 Less: Imputed interest (5,330) Present value of lease liabilities $ 36,590 __________________________ (a) The maturity table excludes cash flows associated with exited lease facilities. Liabilities for exited lease facilities are included in accrued liabilities and other long-term liabilities in the accompanying consolidated balance sheet.

Other Long-term Liabilities O_2

Other Long-term Liabilities Other Long-term Liabilities (Tables)	9 Months Ended
	Sep. 30, 2020
Other Liabilities Disclosure [Abstract]
Other Noncurrent Liabilities [Table Text Block]	Other long-term liabilities consist of the following components (dollars in thousands): September 30, December 31, Non-current asbestos-related liabilities $ 26,840 $ 6,200 Other long-term liabilities 30,410 34,610 Total other long-term liabilities $ 57,250 $ 40,810

Commitments and Contingencies C

Commitments and Contingencies Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Loss Contingencies by Contingency	Claims Claims filed Claims Claims Claims Average Total defense Nine Months Ended September 30, 2020 4,759 159 214 11 4,693 $ 48,864 $ 1,580,000 Fiscal Year Ended December 31, 2019 4,820 143 172 32 4,759 $ 16,616 $ 2,250,000
Schedule of Damages Sought for Specific Claims [Table Text Block]	Below is a breakdown of the compensatory damages sought for those claims seeking specific amounts: Compensatory Range of damages sought (dollars in millions) $0.0 to $0.6 $0.6 to $5.0 $5.0+ Number of claims — 10 46

Segment Information Segment Inf

Segment Information Segment Information (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Segment activity is as follows (dollars in thousands): Three months ended Nine months ended 2020 2019 2020 2019 Net Sales Packaging $ 135,120 $ 105,480 $ 364,000 $ 298,310 Aerospace 39,130 50,560 130,660 145,650 Specialty Products 25,210 32,370 87,140 108,650 Total $ 199,460 $ 188,410 $ 581,800 $ 552,610 Operating Profit (Loss) Packaging $ 28,020 $ 19,740 $ 70,340 $ 60,020 Aerospace (133,500) 7,810 (132,630) 21,270 Specialty Products 3,380 3,620 870 13,730 Corporate (6,220) (7,600) (45,220) (24,590) Total $ (108,320) $ 23,570 $ (106,640) $ 70,430

Equity Awards (Tables)

Equity Awards (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	Information related to stock options at September 30, 2020 is as follows: Number of Weighted Average Option Price Average Remaining Contractual Life (Years) Aggregate Intrinsic Value Outstanding at January 1, 2020 150,000 $ 17.87 Granted — — Exercised — — Cancelled — — Expired — — Outstanding at September 30, 2020 150,000 $ 17.87 5.8 $ 739,500
Schedule of Share-based Compensation, Restricted Stock Units Award Activity	Information related to RSUs at September 30, 2020 is as follows: Number of Unvested RSUs Weighted Average Grant Date Fair Value Average Remaining Contractual Life (Years) Aggregate Intrinsic Value Outstanding at January 1, 2020 622,528 $ 30.77 Granted 485,282 21.42 Vested (302,087) 27.88 Cancelled (17,207) 28.24 Outstanding at September 30, 2020 788,516 $ 26.46 1.5 $ 17,978,165

Defined Benefit Plans (Tables)

Defined Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]
Schedule of Costs of Retirement Plans	The components of net periodic pension cost are as follows (dollars in thousands): Pension Plans Three months ended Nine months ended 2020 2019 2020 2019 Service costs $ 320 $ 270 $ 950 $ 790 Interest costs 240 260 710 800 Expected return on plan assets (380) (350) (1,110) (1,050) Amortization of net loss 220 140 670 430 Net periodic benefit cost $ 400 $ 320 $ 1,220 $ 970

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Other Comprehensive Income [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Changes in AOCI by component for the nine months ended September 30, 2020 are summarized as follows, net of tax (dollars in thousands): Defined Benefit Plans Derivative Instruments Foreign Currency Translation Total Balance, December 31, 2019 $ (9,930) $ 4,230 $ (300) $ (6,000) Net unrealized gains (losses) arising during the period (a) — (2,280) (1,210) (3,490) Less: Net realized losses reclassified to net income (b) (470) — — (470) Net current-period other comprehensive income (loss) 470 (2,280) (1,210) (3,020) Balance, September 30, 2020 $ (9,460) $ 1,950 $ (1,510) $ (9,020) __________________________ (a) Derivative instruments, net of income tax of approximately $0.7 million. See Note 12, " Derivative Instruments ," for further details. (b) Defined benefit plans, net of income tax of approximately $0.1 million. See Note 19, " Defined Benefit Plans ," for further details.	Changes in AOCI by component for the nine months ended September 30, 2019 are summarized as follows, net of tax (dollars in thousands): Defined Benefit Plans Derivative Instruments Foreign Currency Translation Total Balance, December 31, 2018 $ (7,200) $ 940 $ (10,590) $ (16,850) Net unrealized gains (losses) arising during the period (a) — 5,750 (4,380) 1,370 Less: Net realized losses reclassified to net income (b) (300) — — (300) Net current-period other comprehensive income (loss) 300 5,750 (4,380) 1,670 Reclassification of stranded tax effects (1,260) (10) — (1,270) Balance, September 30, 2019 $ (8,160) $ 6,680 $ (14,970) $ (16,450) __________________________ (a) Derivative instruments, net of income tax of approximately $1.8 million. See Note 12, " Derivative Instruments ," for further details.

Basis of Presentation Sale of L

Basis of Presentation Sale of Lamons Division (Details) $ in Millions	Dec. 20, 2019USD ($)
Lamons Division [Member] | Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase price based on definitive sales agreement	$ 135

Discontinued Operations Sale of

Discontinued Operations Sale of Lamons Narrative (Details) - Lamons Division [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Dec. 20, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds on finalization of sale of business	$ 1.8
Discontinued Operations, Disposed of by Sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase price based on definitive sales agreement		$ 135

Discontinued Operations Results

Discontinued Operations Results of Discontinued Operations (Details) - Discontinued Operations, Disposed of by Sale [Member] - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Revenue	$ 48,420	$ 144,880
Disposal Group, Including Discontinued Operation, Costs of Goods Sold	(36,170)	(108,040)
Disposal Group, Including Discontinued Operation, Gross Profit (Loss)	12,250	36,840
Disposal Group, Including Discontinued Operations, SG&A	(7,130)	(21,620)
Disposal Group, Including Discontinued Operation, Operating Income (Loss)	5,120	15,220
Disposal Group, Including Discontinued Operation, Other Expense	10	30
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	5,130	15,250
Discontinued Operation, Tax Effect of Discontinued Operation	(1,260)	(3,540)
Income from discontinued operations	$ 3,870	$ 11,710

Revenue Revenue (Details)

Revenue Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 199,460	$ 188,410	$ 581,800	$ 552,610
Consumer [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	114,220	82,500	298,060	233,250
Aerospace [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	39,130	50,560	130,670	145,650
Industrial [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 46,110	$ 55,350	$ 153,070	$ 173,710

Realignment Actions Realignme_2

Realignment Actions Realignment Actions (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019
Realignment Costs [Line Items]
Loss on dispositions of assets		$ 1,080	$ 60
Realignment actions [Member]
Realignment Costs [Line Items]
Inventory Write-down	$ 13,200
Loss on dispositions of assets	100	2,300
Severance Costs	500	3,600
Cash paid for severance	2,900
Cost of Sales [Member] | Realignment actions [Member]
Realignment Costs [Line Items]
Realignment costs	400	16,400
Selling, General and Administrative Expenses [Member] | Realignment actions [Member]
Realignment Costs [Line Items]
Realignment costs	$ 200	$ 2,700

Acquisitions - Other Acquisitio

Acquisitions - Other Acquisitions (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Feb. 27, 2020
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired							$ 95,160	$ 67,090
Net sales	$ 199,460			$ 188,410			581,800	552,610
Non-cash purchase accounting related expenses								1,200
Rapak [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired		$ 11,400
Net sales									$ 30,000
RSA Engineered Products [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired			$ 83,700
Business Combinations, Assets Acquired and Liabilities Assumed, Goodwill and Intangible Assets											$ 80,200
Business Combination, Recognized Identifiable Assets and Liabilities Assumed, Net Working Capital											10,100
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment											2,100
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities											$ 8,700
Net sales									$ 30,000
Taplast S.p.A. [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired					$ 44,700
Net sales										$ 32,000
Plastic Srl [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired						$ 22,400
Net sales										$ 12,000
Selling, General and Administrative Expenses [Member]
Business Acquisition [Line Items]
Non-cash purchase accounting related expenses								900
Cost of Sales [Member]
Business Acquisition [Line Items]
Non-cash purchase accounting related expenses							$ 2,800	$ 300

Cash and Cash Equivalents (Deta

Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents unrestricted	$ 89,200	$ 172,470
Restricted Cash	10,540	0
Cash and cash equivalents	$ 99,740	$ 172,470

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets Goodwill Narrative (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Mar. 31, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 251,870,000	$ 251,870,000		$ 334,640,000
Goodwill, Impairment Loss		126,840,000
Aerospace Fasteners Reporting Unit [Member]
Goodwill [Line Items]
Goodwill	62,900,000	62,900,000
Aerospace Engineered Products Reporting Unit [Member]
Goodwill [Line Items]
Goodwill	0	0	$ 12,700,000
Aerospace [Member]
Goodwill [Line Items]
Goodwill	$ 62,850,000	62,850,000		$ 133,690,000
Goodwill, Impairment Loss		$ 126,840,000
Goodwill [Member]
Goodwill [Line Items]
Change in discount rate	1.00%	1.00%
Change in terminal growth rate	0.50%	0.50%
Change in goodwill impairment due to change in discount rate	$ 20,000,000	$ 20,000,000
Change in goodwill impairment due to change in terminal rate	5,000,000	$ 5,000,000
Goodwill [Member] | Aerospace [Member] | Aerospace Fasteners Reporting Unit [Member]
Goodwill [Line Items]
Goodwill, Impairment Loss	70,800,000
Goodwill [Member] | Aerospace [Member] | Aerospace Engineered Products Reporting Unit [Member]
Goodwill [Line Items]
Goodwill, Impairment Loss	$ 56,000,000

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets Goodwill Rollforward (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Goodwill [Roll Forward]
Balance, beginning	$ 334,640
Goodwill, Acquired During Period	43,260
Goodwill reassigned between segments	0
Goodwill, Impairment Loss	(126,840)
Translation and purchase accounting adjustments	810
Balance, ending	251,870
Packaging [Member]
Goodwill [Roll Forward]
Balance, beginning	181,650
Goodwill, Acquired During Period	0
Goodwill reassigned between segments	0
Goodwill, Impairment Loss	0
Translation and purchase accounting adjustments	810
Balance, ending	182,460
Aerospace [Member]
Goodwill [Roll Forward]
Balance, beginning	133,690
Goodwill, Acquired During Period	43,260
Goodwill reassigned between segments	12,740
Goodwill, Impairment Loss	(126,840)
Translation and purchase accounting adjustments	0
Balance, ending	62,850
Specialty Products [Member]
Goodwill [Roll Forward]
Balance, beginning	19,300
Goodwill, Acquired During Period	0
Goodwill reassigned between segments	(12,740)
Goodwill, Impairment Loss	0
Translation and purchase accounting adjustments	0
Balance, ending	$ 6,560

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets Other Intangibles Narrative (Details)	3 Months Ended
	Sep. 30, 2020USD ($)
Trade Names [Member] | Aerospace [Member]
Indefinite-lived Intangible Assets [Line Items]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$ 7,800,000

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets Schedule of Intangible Assets (excluding Goodwill) by Major Class (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Intangible Assets, excluding Goodwill [Line Items]
Finite-lived intangible assets, accumulated amortization	$ (188,760)	$ (173,330)
Intangible Assets, Gross (Excluding Goodwill)	364,350	334,720
Trademarks and Trade Names [Member]
Intangible Assets, excluding Goodwill [Line Items]
Indefinite-lived intangible assets, gross carrying amount	44,060	42,850
Customer Relationships [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-lived intangible assets, gross carrying amount	222,880	196,140
Finite-lived intangible assets, accumulated amortization	(117,650)	(105,920)
Technology and Other [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-lived intangible assets, gross carrying amount	97,410	95,730
Finite-lived intangible assets, accumulated amortization	(71,110)	(67,410)
Useful Life Five to Twelve Years [Member] | Customer Relationships [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-lived intangible assets, gross carrying amount	100,610	73,860
Finite-lived intangible assets, accumulated amortization	(56,810)	(49,910)
Useful Life Fifteen to Twentyfive Years [Member] | Customer Relationships [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-lived intangible assets, gross carrying amount	122,270	122,280
Finite-lived intangible assets, accumulated amortization	(60,840)	(56,010)
Useful Life One to Fifteen Years [Member] | Technology and Other [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-lived intangible assets, gross carrying amount	54,110	52,430
Finite-lived intangible assets, accumulated amortization	(32,020)	(29,790)
Useful Life Seventeen to Thirty Years [Member] | Technology and Other [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-lived intangible assets, gross carrying amount	43,300	43,300
Finite-lived intangible assets, accumulated amortization	$ (39,090)	$ (37,620)
Minimum [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	1 year
Minimum [Member] | Useful Life Five to Twelve Years [Member] | Customer Relationships [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	5 years
Minimum [Member] | Useful Life Fifteen to Twentyfive Years [Member] | Customer Relationships [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	15 years
Minimum [Member] | Useful Life One to Fifteen Years [Member] | Technology and Other [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	1 year
Minimum [Member] | Useful Life Seventeen to Thirty Years [Member] | Technology and Other [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	17 years
Maximum [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	30 years
Maximum [Member] | Useful Life Five to Twelve Years [Member] | Customer Relationships [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	12 years
Maximum [Member] | Useful Life Fifteen to Twentyfive Years [Member] | Customer Relationships [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	25 years
Maximum [Member] | Useful Life One to Fifteen Years [Member] | Technology and Other [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	15 years
Maximum [Member] | Useful Life Seventeen to Thirty Years [Member] | Technology and Other [Member]
Intangible Assets, excluding Goodwill [Line Items]
Finite-Lived Intangible Assets, Useful Life	30 years

Goodwill and Other Intangible_7

Goodwill and Other Intangible Assets Schedule of Finite-Lived Intangible Assets, Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Amortization of Intangible Assets [Line Items]
Amortization of intangible assets	$ 5,310	$ 4,650	$ 15,460	$ 14,030
Cost of Sales [Member] | Technology and Other [Member]
Amortization of Intangible Assets [Line Items]
Amortization of intangible assets	1,240	1,190	3,710	3,590
Selling, General and Administrative Expenses [Member] | Customer Relationships [Member]
Amortization of Intangible Assets [Line Items]
Amortization of intangible assets	$ 4,070	$ 3,460	$ 11,750	$ 10,440

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 74,440	$ 68,350
Work in process	29,640	30,560
Raw materials	38,520	33,750
Total inventories	$ 142,600	$ 132,660

Property and Equipment, Net - P

Property and Equipment, Net - Property and Equipment Table (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 450,030	$ 430,980
Less: Accumulated depreciation	234,400	216,650
Property and equipment, net	215,630	214,330
Land and Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	19,800	19,110
Building [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	87,540	84,880
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 342,690	$ 326,990

Property and Equipment, Net - D

Property and Equipment, Net - Depreciation Expense Table (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Depreciation Expense [Line Items]
Depreciation expense			$ 21,700	$ 18,330
Continuing Operations [Member]
Depreciation Expense [Line Items]
Depreciation expense	$ 6,930	$ 6,340	21,700	18,330
Cost of Sales [Member] | Continuing Operations [Member]
Depreciation Expense [Line Items]
Depreciation expense	6,680	6,040	20,870	17,480
Selling, General and Administrative Expenses [Member] | Continuing Operations [Member]
Depreciation Expense [Line Items]
Depreciation expense	$ 250	$ 300	$ 830	$ 850

Long-term Debt - Debt Table (De

Long-term Debt - Debt Table (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Deferred Finance Costs, Net	$ (4,450)	$ (5,310)
Long-term debt, net	295,550	294,690
Senior Notes [Member]
Debt Instrument [Line Items]
Debt	$ 300,000	$ 300,000

Long-term Debt - Senior Notes (

Long-term Debt - Senior Notes (Details) - Senior Notes [Member] - 4.875% Senior Unsecured Notes Due 2025 [Member] $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 300
Debt Instrument, Interest Rate, Stated Percentage	4.875%
Debt Instrument, Maturity Date	Oct. 15, 2025
Prior to October 15, 2020 [Member]
Debt Instrument [Line Items]
Percentage of principal that can be redeemed with cash from proceeds of an equity offering	35.00%
Debt instrument redemption price with net proceeds from equity offering	104.875%
Debt Instrument, Redemption Price, Percentage	100.00%
October 15, 2020 to October 14, 2021 [Member]
Debt Instrument [Line Items]
Debt Instrument, Redemption Price, Percentage	102.438%
October 15, 2021 to October 14, 2022 [Member]
Debt Instrument [Line Items]
Debt Instrument, Redemption Price, Percentage	101.219%
October 15, 2022 and thereafter [Member]
Debt Instrument [Line Items]
Debt Instrument, Redemption Price, Percentage	100.00%

Long-term Debt - Credit Agreeme

Long-term Debt - Credit Agreement (Details) $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
Net leverage ratio	3
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 300
Debt Instrument, Maturity Date	Sep. 20, 2022
Debt Instrument, Basis Spread on Variable Rate	1.50%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving Credit Facility, Capacity Available for Foreign Revolver Loans	$ 125
Line of Credit Facility, Maximum Borrowing Capacity	300
Revolving Credit Facility, Amount Outstanding	0	$ 150	$ 0
Revolving Credit Facility, Remaining Borrowing Capacity	300		283.9
Letters of credit [Member]
Debt Instrument [Line Items]
Letters of Credit, Maximum Borrowing Capacity	40
Letters of Credit Outstanding, Amount	0		$ 16.1
Revolving credit and term loan facilities [Member]
Debt Instrument [Line Items]
Incremental debt commitments capacity	$ 200

Long-term Debt - Fair Value (De

Long-term Debt - Fair Value (Details) - Senior Notes [Member] - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt	$ 300,000	$ 300,000
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 303,000	$ 309,000

Derivative Instruments - Deriva

Derivative Instruments - Derivative Narrative (Details) - Designated as Hedging Instrument [Member] - Cross Currency Interest Rate Contract [Member] - Net Investment Hedging [Member] $ in Millions	3 Months Ended
	Sep. 30, 2020USD ($)
Derivative [Line Items]
Maximum Remaining Maturity of Foreign Currency Derivatives	5 years
Derivative, Fixed Interest Rate	2.90%
Maximum [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 125
Minimum [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 75

Derivative Instruments - Design

Derivative Instruments - Designated as hedging, Financial Position (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Net Investment Hedging [Member] | Cross Currency Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Asset Derivatives	$ 1,490	$ 4,460

Derivative Instruments - Desi_2

Derivative Instruments - Designated as hedging, Financial Performance (Details) - Net Investment Hedging [Member] - Designated as Hedging Instrument [Member] - Cross Currency Interest Rate Contract [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	$ 1,950		$ 1,950		$ 4,230
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 0	$ 0	$ 0	$ 0

Derivative Instruments - Desi_3

Derivative Instruments - Designated as hedging, Financial Performance Narrative (Details) - Designated as Hedging Instrument [Member] $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassification from AOCI into Earnings, Estimate of Time to Transfer	12 months
Amount of gain (loss) expected to be reclassified from AOCI into Earnings	$ 0

Derivative Instruments - Deri_2

Derivative Instruments - Derivatives not designated as hedging instruments (Details) - Not Designated as Hedging Instrument [Member] - Foreign Exchange Contract [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Derivative [Line Items]
Derivative, Notional Amount	$ 63,500		$ 63,500
Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net	$ 800	$ 1,170	$ 1,280	$ 1,390

Derivative Instruments - Fair V

Derivative Instruments - Fair Value Measurements (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Cross Currency Interest Rate Contract [Member] | Net Investment Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Instruments in Hedges, at Fair Value, Net	$ 1,490	$ 4,460
Cross Currency Interest Rate Contract [Member] | Net Investment Hedging [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Instruments in Hedges, at Fair Value, Net	0	0
Cross Currency Interest Rate Contract [Member] | Net Investment Hedging [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Instruments in Hedges, at Fair Value, Net	1,490	4,460
Cross Currency Interest Rate Contract [Member] | Net Investment Hedging [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Instruments in Hedges, at Fair Value, Net	0	0
Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Derivatives Not Designated as Hedging Instruments at Fair Value, Net	(350)	(770)
Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Derivatives Not Designated as Hedging Instruments at Fair Value, Net	0	0
Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Derivatives Not Designated as Hedging Instruments at Fair Value, Net	(350)	(770)
Foreign Exchange Contract [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other Derivatives Not Designated as Hedging Instruments at Fair Value, Net	$ 0	$ 0

Leases Lease Cost Table (Detail

Leases Lease Cost Table (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Leases [Abstract]
Operating Lease, Cost	$ 2,110	$ 1,610	$ 5,780	$ 4,750
Short-term, variable and other lease costs	410	230	990	640
Lease, Cost	$ 2,520	$ 1,840	$ 6,770	$ 5,390

Leases Operating Lease Liabilit

Leases Operating Lease Liability Maturity Table (Details) $ in Thousands	Sep. 30, 2020USD ($)	[1]
Leases [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year	$ 2,080
Lessee, Operating Lease, Liability, to be Paid, Year One	7,680
Lessee, Operating Lease, Liability, to be Paid, Year Two	6,900
Lessee, Operating Lease, Liability, to be Paid, Year Three	5,940
Lessee, Operating Lease, Liability, to be Paid, Year Four	4,730
Lessee, Operating Lease, Liability, to be Paid, after Year Four	14,590
Lessee, Operating Lease, Liability, to be Paid	41,920
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(5,330)
Operating Lease, Liability	$ 36,590
[1]	(a) The maturity table excludes cash flows associated with exited lease facilities. Liabilities for exited lease facilities are included in accrued liabilities and other long-term liabilities in the accompanying consolidated balance sheet.

Leases Supplemental Balance She

Leases Supplemental Balance Sheet Information Related to Leases (Details)	Sep. 30, 2020Rate
Leases [Abstract]
Operating Lease, Weighted Average Remaining Lease Term	6 years 7 months 6 days
Operating Lease, Weighted Average Discount Rate, Percent	4.50%

Leases Supplemental Cash Flow I

Leases Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Leases [Abstract]
Operating Lease, Payments	$ 5.4	$ 4.9
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 10.5	$ 0.9

Other Long-term Liabilities O_3

Other Long-term Liabilities Other Long-term Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Other Liabilities Disclosure [Abstract]
Asbestos-related liability noncurrent	$ 26,840	$ 6,200
Other long-term liabilities other than asbestos liability	30,410	34,610
Other Liabilities, Noncurrent	$ 57,250	$ 40,810

Commitments and Contingencies A

Commitments and Contingencies Asbestos Narrative (Details) - Asbestos [Member]	3 Months Ended		9 Months Ended	30 Months Ended	351 Months Ended
	Jun. 30, 2020USD ($)	Mar. 31, 2019USD ($)claimants	Sep. 30, 2020USD ($)claimantscases	Jun. 30, 2020USD ($)claimants	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)claimants	Dec. 31, 2018claimants
Loss Contingencies [Line Items]
Liabilities Subject to Compromise, Asbestos Obligations			$ 29,400,000
Loss Contingency, Pending Cases, Number | cases			374
Loss Contingency, Pending Claims, Number | claimants			4,693			4,759	4,820
Total settlement costs					$ 9,900,000
Loss Contingency, New Claims Filed, Number | claimants		143	159
Percentage of settlement and defense costs covered by insurance					40.00%
Legal Fees		$ 2,250,000	$ 1,580,000
Minimum [Member]
Loss Contingencies [Line Items]
Liabilities Subject to Compromise, Asbestos Obligations						$ 31,500,000
Loss Contingency, New Claims Filed, Number | claimants				143
Legal Fees				$ 2,200,000
Maximum [Member]
Loss Contingencies [Line Items]
Liabilities Subject to Compromise, Asbestos Obligations						$ 43,300,000
Loss Contingency, New Claims Filed, Number | claimants				173
Legal Fees				$ 2,300,000
Compensatory Only Damages [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of pending claims seeking specific amounts of damages | claimants			56
Selling, General and Administrative Expenses [Member]
Loss Contingencies [Line Items]
Impact of change in accounting principle	$ 23,400,000

Commitments and Contingencies_2

Commitments and Contingencies Asbestos Claimant and Settlement (Details) - Asbestos [Member]	3 Months Ended	9 Months Ended
	Mar. 31, 2019USD ($)claimants	Sep. 30, 2020USD ($)claimants	Dec. 31, 2019claimants	Dec. 31, 2018claimants
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number		4,693	4,759	4,820
Loss Contingency, New Claims Filed, Number	143	159
Loss Contingency, Claims Dismissed, Number	172	214
Loss Contingency, Claims Settled, Number	32	11
Average settlement amount per claim during period | $	$ 16,616	$ 48,864
Legal Fees | $	$ 2,250,000	$ 1,580,000

Commitments and Contingencies_3

Commitments and Contingencies Asbestos Damages Sought (Details) - Asbestos [Member] $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)claimants
Compensatory and Punitive Damages [Member] | Range 1 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 0
Compensatory and Punitive Damages [Member] | Range 1 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	0.6
Compensatory and Punitive Damages [Member] | Range 2 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	0.6
Compensatory and Punitive Damages [Member] | Range 2 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	5
Compensatory and Punitive Damages [Member] | Range 3 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	5
Compensatory Only Damages [Member] | Range 1 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	0
Compensatory Only Damages [Member] | Range 1 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	0.6
Compensatory Only Damages [Member] | Range 2 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	0.6
Compensatory Only Damages [Member] | Range 2 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	5
Compensatory Only Damages [Member] | Range 3 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	5
Punitive Only Damages [Member] | Range 1 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	0
Punitive Only Damages [Member] | Range 1 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	2.5
Punitive Only Damages [Member] | Range 2 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	2.5
Punitive Only Damages [Member] | Range 2 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	5
Punitive Only Damages [Member] | Range 3 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 5
Pending Litigation [Member] | Compensatory Only Damages [Member]
Loss Contingencies [Line Items]
Number of pending claims seeking specific amounts of damages | claimants	56
Pending Litigation [Member] | Compensatory Only Damages [Member] | Range 1 [Member]
Loss Contingencies [Line Items]
Number of pending claims seeking specific amounts of damages | claimants	0
Pending Litigation [Member] | Compensatory Only Damages [Member] | Range 2 [Member]
Loss Contingencies [Line Items]
Number of pending claims seeking specific amounts of damages | claimants	10
Pending Litigation [Member] | Compensatory Only Damages [Member] | Range 3 [Member]
Loss Contingencies [Line Items]
Number of pending claims seeking specific amounts of damages | claimants	46

Segment Information Segment I_2

Segment Information Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Net sales	$ 199,460	$ 188,410	$ 581,800	$ 552,610
Operating profit (loss)	(108,320)	23,570	(106,640)	70,430
Operating Segments [Member] | Packaging [Member]
Segment Reporting Information [Line Items]
Net sales	135,120	105,480	364,000	298,310
Operating profit (loss)	28,020	19,740	70,340	60,020
Operating Segments [Member] | Aerospace [Member]
Segment Reporting Information [Line Items]
Net sales	39,130	50,560	130,660	145,650
Operating profit (loss)	(133,500)	7,810	(132,630)	21,270
Operating Segments [Member] | Specialty Products [Member]
Segment Reporting Information [Line Items]
Net sales	25,210	32,370	87,140	108,650
Operating profit (loss)	3,380	3,620	870	13,730
Corporate, Non-Segment [Member] | Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Operating profit (loss)	$ (6,220)	$ (7,600)	$ (45,220)	$ (24,590)

Equity Awards - Stock Option Ac

Equity Awards - Stock Option Activity Table (Details)	9 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options Outstanding, beginning balance | shares	150,000
Number of Options Granted | shares	0
Number of Options Exercised | shares	0
Number of Options Cancelled | shares	0
Number of Options Expired | shares	0
Number of Options Outstanding, ending balance | shares	150,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Options Outstanding, Weighted Average Price, beginning | $ / shares	$ 17.87
Options Granted, Weighted Average Price | $ / shares	0
Options Exercised, Weighted Average Price | $ / shares	0
Options Cancelled, Weighted Average Price | $ / shares	0
Options Expired, Weighted Average Price | $ / shares	0
Options Outstanding, Weighted Average Price, ending | $ / shares	$ 17.87
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures
Options Average Remaining Contractual Life (Years)	5 years 9 months 18 days
Options Aggregate Intrinsic Value | $	$ 739,500

Equity Awards - Stock Options N

Equity Awards - Stock Options Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount	$ 0		$ 0
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercisable stock options	150,000		150,000
Selling, General and Administrative Expenses [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 0	$ 100,000	$ 0	$ 100,000

Equity Awards - Restricted Stoc

Equity Awards - Restricted Stock Units Activity Table (Details) - Restricted Stock Units [Member]	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Unvested Restricted Stock Units Outstanding, beginning balance | shares	622,528
Number of Unvested Restricted Stock Units Granted | shares	485,282
Number of Unvested Restricted Stock Units Vested | shares	(302,087)
Number of Unvested Restricted Stock Units Cancelled | shares	(17,207)
Number of Unvested Restricted Stock Units Outstanding, ending balance | shares	788,516
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Unvested Restricted Stock Units Outstanding, Weighted Average Grant Date Fair Value, beginning	$ 30.77
Unvested Restricted Stock Units Granted, Weighted Average Grant Date Fair Value	21.42
Unvested Restricted Stock Units Vested, Weighted Average Grant Date Fair Value	27.88
Unvested Restricted Stock Units Cancelled, Weighted Average Grant Date Fair Value	28.24
Unvested Restricted Stock Units Outstanding, Weighted Average Grant Date Fair Value, ending	$ 26.46
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures
Restricted Stock Units Average Remaining Contractual Life (Years)	1 year 6 months
Restricted Stock Units Aggregate Intrinsic Value	$ 17,978,165

Equity Awards - Restricted St_2

Equity Awards - Restricted Stock Units Narrative (Details) - Restricted Stock Units [Member] - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares issued related to director fee deferrals				3,222
Number of Unvested Restricted Stock Units Granted				485,282
Unrecognized unvested restricted shares-based compensation expense	$ 10.3			$ 10.3
Weighted-average period for recognition of the unrecognized unvested restricted shares-based compensation expense				2 years 1 month 6 days
Plan 1 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Unvested Restricted Stock Units Granted				189,349
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period				3 years
Plan 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Unvested Restricted Stock Units Granted				87,034
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period				3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate				0.85%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				25.20%
Plan 4 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Unvested Restricted Stock Units Granted				31,816
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period				3 years
Plan 5 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Unvested Restricted Stock Units Granted				2,558
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period				1 year
Plan 7 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Unvested Restricted Stock Units Granted				30,590
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period				1 year
Plan 8 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Unvested Restricted Stock Units Granted				113,146
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period				3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate				0.56%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				26.20%
3 year EPS CAGR metric [Member] | Maximum [Member] | Plan 8 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award percentage earned based on metric over the performance period				50.00%
Total shareholder return metric [Member] | Plan 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Unvested Restricted Stock Units Granted				27,567
Share-based Compensation Arrangement by Share-based Payment Award, Award percentage attained		127.40%
Total shareholder return metric [Member] | Minimum [Member] | Plan 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Amount of shares earned % of target award				0.00%
Total shareholder return metric [Member] | Minimum [Member] | Plan 8 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Amount of shares earned % of target award				0.00%
Total shareholder return metric [Member] | Maximum [Member] | Plan 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Amount of shares earned % of target award				200.00%
Total shareholder return metric [Member] | Maximum [Member] | Plan 8 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award percentage earned based on metric over the performance period				50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Amount of shares earned % of target award				200.00%
Average stock price [Member] | Minimum [Member] | Plan 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Amount of shares earned % of target award				0.00%
Average stock price [Member] | Maximum [Member] | Plan 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Amount of shares earned % of target award				160.00%
Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares-based compensation expense	$ 0.9		$ 1	$ 5.6	$ 3.9

Earnings per Share Earnings per

Earnings per Share Earnings per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted average common shares—basic	43,457,704	45,175,244	43,707,331	45,448,711
Weighted average common shares—diluted	43,457,704	45,415,767	43,707,331	45,745,421
Restricted Stock Units (RSUs) [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Incremental common shares attributable to share-based payment arrangements	0	179,418	0	229,003
Stock Options [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Incremental common shares attributable to share-based payment arrangements	0	61,105	0	67,707

Earnings per Share Repurchase o

Earnings per Share Repurchase of Common Stock (Details) - USD ($)	3 Months Ended					9 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2015
Stock Repurchased and Retired During Period, Value	$ 4,480,000	$ 31,570,000	$ 5,670,000	$ 14,750,000	$ 670,000
10b5-1 share repurchase program [Member]
Stock Repurchase Program, Authorized Amount	$ 250,000,000					$ 250,000,000		$ 50,000,000
Stock Repurchased and Retired During Period, Shares	188,028		196,128			1,441,678	723,528
Stock Repurchased and Retired During Period, Value	$ 4,500,000		$ 5,700,000			$ 36,000,000	$ 21,100,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 165,100,000					$ 165,100,000

Defined Benefit Plans - Net Per

Defined Benefit Plans - Net Periodic Pension Costs (Details) - Pension Plans, Defined Benefit [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service costs	$ 320	$ 270	$ 950	$ 790
Interest costs	240	260	710	800
Expected return on plan assets	(380)	(350)	(1,110)	(1,050)
Amortization of net (gain)/loss	220	140	670	430
Net periodic benefit cost	$ 400	$ 320	$ 1,220	$ 970

Defined Benefit Plans - Defined

Defined Benefit Plans - Defined Benefit Plans Narrative (Details) - Pension Plans, Defined Benefit [Member] $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Contributions by Employer	$ 0.2	$ 0.9
Defined Benefit Plan, Estimated Future Employer Contributions in Current Fiscal Year	$ 2.3	$ 2.3

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020		Sep. 30, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances	$ 661,100	$ 675,460	$ 697,480	$ 647,360	$ 640,510	$ 620,450	$ 697,480		$ 620,450
Total other comprehensive income (loss)	1,320	(660)	(3,680)	180	(1,530)	3,020	(3,020)		1,670
Balances	557,970	661,100	675,460	662,060	647,360	640,510	557,970		662,060
Other Comprehensive Income (Loss), Tax [Abstract]
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax							(700)		1,800
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax							100		100
Defined Benefit Plans [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances			(9,930)			(7,200)	(9,930)		(7,200)
Net unrealized gains (losses) arising during the period							0		0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax							(470)	[1]	(300)	[2]
Total other comprehensive income (loss)							470		300
Reclassification of stranded tax effects									(1,260)
Balances	(9,460)			(8,160)			(9,460)		(8,160)
Accumulated Net Gain (Loss) from Hedges Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances			4,230			940	4,230		940
Net unrealized gains (losses) arising during the period							(2,280)	[3]	5,750	[4]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax							0		0
Total other comprehensive income (loss)							(2,280)		5,750
Reclassification of stranded tax effects									(10)
Balances	1,950			6,680			1,950		6,680
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances			(300)			(10,590)	(300)		(10,590)
Net unrealized gains (losses) arising during the period							(1,210)		(4,380)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax							0		0
Total other comprehensive income (loss)							(1,210)		(4,380)
Reclassification of stranded tax effects									0
Balances	(1,510)			(14,970)			(1,510)		(14,970)
Accumulated Other Comprehensive Income [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balances	(10,340)	(9,680)	(6,000)	(16,630)	(15,100)	(16,850)	(6,000)		(16,850)
Net unrealized gains (losses) arising during the period							(3,490)		1,370
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax							(470)		(300)
Total other comprehensive income (loss)	1,320	(660)	(3,680)	180	(1,530)	3,020	(3,020)		1,670
Reclassification of stranded tax effects									(1,270)
Balances	$ (9,020)	$ (10,340)	$ (9,680)	$ (16,450)	$ (16,630)	$ (15,100)	$ (9,020)		$ (16,450)
[1]	Defined benefit plans, net of income tax of approximately $0.1 million. See Note 19, " Defined Benefit Plans ," for further details.
[2]	Defined benefit plans, net of income tax of approximately $0.1 million. See Note 19, " Defined Benefit Plans ," for further details.
[3]	Derivative instruments, net of income tax of approximately $0.7 million. See Note 12, " Derivative Instruments ," for further details.
[4]	Derivative instruments, net of income tax of approximately $1.8 million. See Note 12, " Derivative Instruments ," for further details.

Subsequent Event Acquisition (D

Subsequent Event Acquisition (Details) - Affaba & Ferrari Srl [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Oct. 27, 2020
Subsequent Event [Line Items]
Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period	$ 35,000,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Purchase price based on definitive sales agreement		$ 84,000,000

Uncategorized Items - trs-20200

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 57,940,000